1. Metagenomics and antibiotics
L. Garmendia, A. Hernandez, M.B. Sanchez, J.L. Martinez 
Clinical Microbiology and Infection 
Volume 18, Pages (July 2012)
DOI: /j x
Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

2. FIG. 1
Number of papers on antibiotics and metagenomics that can be found on PubMed. The figure shows the distribution along time of papers recorded in PubMed using the query [(metagenomic*) AND (antibiotic* OR antimicrobial*)]. The search was made on 17 October 2011.
Clinical Microbiology and Infection  , 27-31DOI: ( /j x)
Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

3. FIG. 2
Second-order selection of resistant clones or elements harbouring antibiotic resistance. The acquisition of resistance by a member of a complex microbiota has consequences for the structure of such microbiota that will depend on the presence of an antibiotic. In the absence of antibiotic selective pressure, if the microbiota contains intrinsically resistant microorganisms (black ovals) or one of the members acquires a resistance determinant (star inside ovals), the intrinsically resistant clone will be maintained at the same rate and the acquired resistance gene will probably be lost if it confers a fitness cost (b). In these circumstances it is expected that the homeostasis of the system is maintained (c). However, if the microbiota is submitted to antibiotic selective pressure (d), intrinsically resistant clones will expand at the expense of the susceptible ones that are killed by the antibiotics. In a similar way, those microorganisms acquiring the resistance element will survive allowing the expansion of the specific clones harbouring the resistance determinant. Finally, the transfer of the resistance element will allow the survival of other bacterial clones/species in the presence of the antibiotic. As the consequence, the successful spread of this element will be increased by a second-order selection process.
Clinical Microbiology and Infection  , 27-31DOI: ( /j x)
Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions